4.7 Article

Synthesis of benzylidene-benzofuranone derivatives as probes for detection of amyloid fibrils in cells

Journal

Publisher

TAYLOR & FRANCIS INC
DOI: 10.1080/07391102.2023.2184635

Keywords

Neurodegenerative diseases; Amyloid beta; Insulin; Benzylidene derivatives; Benzofuranone derivatives

Ask authors/readers for more resources

Aggregated protein, such as amyloid beta, is a common cause of neurodegenerative diseases like Alzheimer's and Parkinson's. Detecting and quantifying amyloid in the early stages of the disease is crucial for its treatment and prevention. In this study, 17 new biomarker compounds were synthesized to detect and identify amyloid in vitro and in cells, showing promising results in terms of selectivity and detectability of amyloid fibrils. Compound 10 exhibited the best binding properties and was able to detect intracellular amyloid in vivo.
Aggregated protein is the common cause of a wide variety of neurodegenerative diseases, such as Alzheimer's disease (AD), Parkinson's disease, etc. It is proven that protein aggregation like amyloid beta (A beta) is one of the critical factors causing AD and, its diagnosis in the early stages of the disease is important for the treatment or prevention of AD. To have a better understanding of protein aggregation and its pathologies, there is a huge need to design and develop new and more trustworthy probe molecules for in vitro amyloid quantification and in vivo amyloid imaging. In this study, 17 new biomarker compounds, have been synthesized from benzofuranone derivatives, to detect and identify amyloid in vitro (dye-binding assay) as well as in the cell by staining method. According to the results, some of these synthetic derivatives can be considered suitable identifiers and quantifiers to detect amyloid fibrils in vitro. Compared to thioflavin T, 4 probes out of 17 probes have shown good results in selectivity and detectability of A beta depositions, and their binding properties were also confirmed with in silico analysis. The drug-likeness prediction results for selected compounds by the Swiss ADME server show a satisfactory percentage of blood-brain barrier (BBB) permeability and gastrointestinal (GI) absorption. Among all of them, compound 10 was able to show better binding properties than others, and in vivo study showed that this compound was capable of detecting intracellular amyloid.Communicated by Ramaswamy H. Sarma

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available